Dechra Pharmaceuticals (DPH)

 

DPH Share PerformanceMore

52 week high2,840.0 02/05/18
52 week low1,636.0 14/07/17
52 week change 832.0 (44.07%)
4 week volume5,387,559 01/05/18
price2,720.0
price date1527269939
close2,744.0

Latest NewsMore

Total Voting Rights

RNS Number: 5531M Dechra Pharmaceuticals PLC 30 April 2018 30 April 2018 Dechra Pharmaceuticals PLC (Dechra or the Company) LEI: 213800J4UVB5OWG8VX82 Total Voting Rights In conformity with DTR 5.6.1R, the Company notifies the market of the following: As at the date of this announcement, the Company's issued share capital consists of 102,326,635 or...

The UK smaller companies that stock pickers love

Fears that Brexit would hurt smaller companies have been shrugged off, with the sector beating all comers. Rebecca Jones...

Total Voting Rights

RNS Number: 5982J Dechra Pharmaceuticals PLC 03 April 2018 3 April 2018 Dechra Pharmaceuticals PLC (Dechra or the Company) LEI: 213800J4UVB5OWG8VX82 Total Voting Rights In conformity with DTR 5.6.1R, the Company notifies the market of the following: As at the date of this announcement, the Company's issued share capital consists of 102,315,783 ordin...

Additional Listing

RNS Number: 8491H Dechra Pharmaceuticals PLC 15 March 2018 15 March 2018 Dechra Pharmaceuticals PLC (Dechra or the Company) Additional Listing An application has been made to the Financial Conduct Authority and the London Stock Exchange for a total of 70,000 ordinary shares of 1 pence each (the "Shares") to be admitted to the Official List. These Sha...

Block listing six monthly return

RNS Number: 7543H Dechra Pharmaceuticals PLC 15 March 2018 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically and provided to an ris . Date: 15 March 2018 Name of applicant: Dechra Pharmaceuticals PLC Name of scheme: Long-Term Incentive Scheme Period of return: From: 15 September...

Director Deals - Dechra Pharmaceuticals PLC (DPH)

Ian Page, Chief Executive Officer, exercised 1,465 shares in the company on the 2nd March 2018 at a price of 614.00p. The D...

Director/PDMR Shareholding

RNS Number: 6917G Dechra Pharmaceuticals PLC 05 March 2018 5 March 2018 Dechra Pharmaceuticals PLC (Dechra or the Company) LEI: 213800J4UVB5OWG8VX82 Notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs) Exercise of SAYE options: Dechra Pharmaceuticals PLC announces that on 2 March 20...

Director/PDMR Shareholding

RNS Number: 6734G Dechra Pharmaceuticals PLC 05 March 2018 5 March 2018 Dechra Pharmaceuticals PLC (Dechra or the Company) LEI: 213800J4UVB5OWG8VX82 Notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs) The Company announces that on 2 March 2018 the following Directors were granted a...

Fundamental DataMore

P/E ratio96.832
EPS28.09
Dividend yield0.788 %

Latest discussion posts More

  • NEW ARTICLE: The UK smaller companies beating the Brexit blues

    "The UK smaller companies fund sector is historically a strong performer on a long-term view. Over the past 10 years to 14 February, it has returned more than any other UK ...
    13-Apr-2018
    II Editor
  • Re: #30 by year end?

    Now up 200% since investment in February 2015. Mote to come, I think, and with fairly low risk. Cheers, Frog in a tree
    9-Apr-2018
    frog in a tree
  • Re: #30 by year end?

    Checked today and up 27.7% year to date. Very much against the market trend. A winner! Cheers, Frog in a tree
    15-Mar-2018
    frog in a tree

Users' HoldingsMore

Users who hold Dechra Pharmaceuticals also hold..

Codes & Symbols

ISINGB0009633180
SymbolsDPH, LSE:DPH, DPH.L, DPH:LN, LON:DPH, XLON:DPH